There has been a push toward animal-free alternatives in scientific research. But the success of such alternatives hinges upon whether and where they can outperform standard animal models.
Really fascinatin to see CRL pivoting towards alternative methods while they're still the biggest lab animal supplier. Its like watching a company hedge their bets on both sides of the transition. Makes sense though, if NAMs are the future they want to be positioned for it rather than get left behind. The fact that they launced this in 2024 shows they're taking the regulatory shifts seriously.
Really fascinatin to see CRL pivoting towards alternative methods while they're still the biggest lab animal supplier. Its like watching a company hedge their bets on both sides of the transition. Makes sense though, if NAMs are the future they want to be positioned for it rather than get left behind. The fact that they launced this in 2024 shows they're taking the regulatory shifts seriously.